Prescription drug · NDA AUTHORIZED GENERIC
Voriconazole NDC 59762-0935
Voriconazole 40 mg/mL · Powder, For suspension · Oral · Mylan Pharmaceuticals Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 59762-0935-3 | 5976209350359762093503 | 1 BOTTLE in 1 CARTON (59762-0935-3) / 75 mL in 1 BOTTLEMarketed from Dec 16, 2013 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Voriconazole
- Generic name (nonproprietary)
- voriconazole
- Active ingredients
- Voriconazole — 40 mg/mL
- Dosage form
- Powder, For suspension
- Route
- Oral
- Labeler
- Mylan Pharmaceuticals Inc.NDC labeler code 59762
- Product type
- Prescription drug
- Marketing category
- NDA authorized genericApplication NDA 021630
- Marketing start
- Listing expires
- Other FDA classes
- Azoles (Chemical structure)Cytochrome P450 2C19 Inhibitors (Mechanism)Cytochrome P450 2C9 Inhibitors (Mechanism)Cytochrome P450 3A4 Inhibitors (Mechanism)
- Identifiers
- Product ID 59762-0935_7131a7cd-db5a-4ac2-9a84-09059d62669eSPL ID 7131a7cd-db5a-4ac2-9a84-09059d62669eSPL set ID b8de04a0-238d-4e0b-b0d9-7f7878b149d4RxCUI 465355UNII JFU09I87TRUPC 0359762093530
- Pharmacologic class
- Azole Antifungal
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N459762093503followed by a unit qualifier and the quantityPackage 59762-0935-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Voriconazole is an azole antifungal indicated for the treatment of adults and pediatric patients 2 years of age and older with: • Invasive aspergillosis ( 1.1 ) • Candidemia in non-neutropenics and other deep tissue Candida infections ( 1.2 ) • Esophageal candidiasis ( 1.3 ) • Serious fungal infections caused by Scedosporium apiospermum and Fusarium species including Fusarium solani , in patients intolerant of, or refractory to, other therapy ( 1.4 ) 1.1 Invasive Aspergillosis Voriconazole is indicated in adults and pediatric patients (2 years of age and older) for the treatment of invasive aspergillosis (IA). In clinical trials, the majority of isolates recovered were Aspergillus fumigatus …
Excerpt only. Read the full label for complete information.
About NDC 59762-0935
- What is NDC 59762-0935?
- 59762-0935 is the product NDC for Voriconazole, Voriconazole 40 mg/mL powder, for suspension, listed with the FDA by Mylan Pharmaceuticals Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Voriconazole.
- What is the active ingredient?
- Voriconazole.
- Who is the labeler?
- Mylan Pharmaceuticals Inc., NDC labeler code 59762. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Voriconazole?
- 52 other product NDCs are listed under this name. See all Voriconazole NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Voriconazole products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Voriconazole | Voriconazole 50 mg/1 | Tablet, Film coatedOral | American Health Packaging | 60687-968 | 60687-0968-21 |
| Voriconazole | Voriconazole 200 mg/1 | Tablet, Film coatedOral | American Health Packaging | 60687-979 | 60687-0979-21 |
| Voriconazolevoriconazole injection | Voriconazole 10 mg/mL | InjectionIntravenous | PAI Holdings, LLC dba PAI Pharma | 0121-1091 | 00121-1091-55 |
| Voriconazole | Voriconazole 50 mg/1 | Tablet, Film coatedOral | Safecor Health LLC | 48433-146 | 48433-0146-03 |
| Voriconazole | Voriconazole 200 mg/1 | Tablet, Film coatedOral | Safecor Health LLC | 48433-147 | 48433-0147-03 |
| Voriconazole | Voriconazole 10 mg/mL | Injection, SolutionIntravenous | Hainan Poly Pharm. Co., Ltd. | 14335-730 | 14335-0730-10 |
| Voriconazole | Voriconazole 40 mg/mL | Powder, For suspensionOral | Camber Pharmaceuticals, Inc. | 31722-266 | 31722-0266-31 |
| voriconazole | Voriconazole 200 mg/1 | Tablet, Film coatedOral | Bryant Ranch Prepack | 72162-1198 | 72162-1198-03 |
| voriconazole | Voriconazole 40 mg/mL | Powder, For suspensionOral | Zhejiang Poly Pharm Co., Ltd. | 72673-111 | 72673-0111-30 |
| Voriconazole | Voriconazole 10 mg/mL | Injection, Powder, Lyophilized, For solutionIntravenous | Camber Pharmaceuticals, Inc. | 31722-224 | 31722-0224-31 |
Other NDCs under NDA 021630
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.